Utilization
of nitrogen mustards as anticancer drugs opened the
way for precise cancer chemotherapy owing to their ability to cross-link
deoxyribonucleic acid (DNA). However, the non-specificity and lower
water solubility limit their aptitude to behave as effective anticancer
drugs. Herein we embed the clinically approved nitrogen mustard, chlorambucil
(CBL), into a redox-responsive polymeric vector to overcome those
bottlenecks as well as to achieve better efficacy. We have synthesized
amphiphilic diblock copolymers (BCPs) consisting of polymerized segments
of a pendent disulfide-labeled CBL prodrug monomer and hydrophilic
2-(dimethylamino)ethyl methacrylate monomer via reversible addition–fragmentation
chain transfer polymerization. The well-defined polyprodrug amphiphiles
with CBL loading content >40 wt% could form uniform micelles with
an average diameter of 45–110 nm through a macromolecular self-assembly
strategy. For the release of caged CBL, disassembly of the self-assembled
micelles was attained under reducing conditions, confirmed through
dynamic light scattering and field emission scanning electron microscopy. In vitro evaluation of CBL release showed that the percentage
of drug release was profoundly enhanced up to >90% in the presence
of 5 mM d,l-dithiothreitol. Cytotoxicity studies
against a triple-negative breast cancer (MDA-MB-231) cell line revealed
that the BCP has much better cytotoxicity than the free CBL. Furthermore,
the alkylating activity of BCP was confirmed using a colorimetric
indicator, 4-(4-nitrobenzyl)pyridine, and upon agarose gel electrophoresis
with pUC19 plasmid DNA. Combining the features of redox-responsive
drug release and DNA alkylation, BCPs provide insight into drug delivery
and disrupt the thiol-rich environment of cancer cells.